Cargando…

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Schmitz, M, Temme, A, Senner, V, Ebner, R, Schwind, S, Stevanovic, S, Wehner, R, Schackert, G, Schackert, H K, Fussel, M, Bachmann, M, Rieber, E P, Weigle, B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359969/ http://dx.doi.org/10.1038/sj.bjc.6603802

Ejemplares similares

Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
por: Schmitz, M, et al.
Publicado: (2007)

Identification of an HLA-A(*)0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein
por: Kiessling, A, et al.
Publicado: (2004)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
por: Kiessling, Andrea, et al.
Publicado: (2012)

SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells
por: Oppel, Felix, et al.
Publicado: (2011)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)

GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo
por: Scheuring, Urban J., et al.
Publicado: (2021)

Tumor Evasion from T Cell Surveillance
por: Töpfer, Katrin, et al.
Publicado: (2011)

Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
por: Conde, Marina, et al.
Publicado: (2017)

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011)

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]
Publicado: (2022)

Molecular Characterization of Astrocytoma Progression Towards Secondary Glioblastomas Utilizing Patient-Matched Tumor Pairs
por: Seifert, Michael, et al.
Publicado: (2020)

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
por: Xiang, R, et al.
Publicado: (2011)

A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
por: Bippes, Claudia C., et al.
Publicado: (2011)

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53
por: Wiedemuth, Ralf, et al.
Publicado: (2014)

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
por: Schau, Isabell, et al.
Publicado: (2019)

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
por: Rocha, C R R, et al.
Publicado: (2015)

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
por: D'Angelo, S. P., et al.
Publicado: (2015)

CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2009)

Scanning tunneling spectroscopy on electron-boson interactions in superconductors
por: Schackert, Michael Peter
Publicado: (2015)

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma
por: Pontisso, P, et al.
Publicado: (2004)

SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation
por: Stevanovic, Milena, et al.
Publicado: (2021)

The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
por: Dosani, T, et al.
Publicado: (2015)

Corrigendum to “Structural Stability, Transitions, and Interactions within SoxYZCD-Thiosulphate from Sulfurimonas denitrificans: An In Silico Molecular Outlook for Maintaining Environmental Sulphur Cycle”
por: Ray, Sujay, et al.
Publicado: (2016)

Corrigendum to: SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21(CIPI), cyclin D1 and β‐catenin
Publicado: (2020)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis [Corrigendum]
Publicado: (2021)

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma
por: Liu, Yibin, et al.
Publicado: (2023)

[Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling
por: Lei, Zhengwen, et al.
Publicado: (2023)

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Cheng, Ling-Gang, et al.
Publicado: (2017)

CIRP Regulates BEV-Induced Cell Migration in Gliomas [Corrigendum]
Publicado: (2020)

Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers
por: Jugel, Willi, et al.
Publicado: (2022)

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
por: Jugel, Willi, et al.
Publicado: (2021)

Mobile phone use and risk of glioma in adults: case–control study
por: Milham, S
Publicado: (2006)

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
por: Tunger, Antje, et al.
Publicado: (2018)

Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas
por: Hill, Victoria K, et al.
Publicado: (2014)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
por: Abbott, Rebecca C, et al.
Publicado: (2021)

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
por: Hottinger, A F, et al.
Publicado: (2018)

Knockdown of pseudogene DUXAP8 expression in glioma suppresses tumor cell proliferation
por: Zhao, Xu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mc0efurvamng2hc39mhribr48q